PRESCRIPTION PATTERN OF PROPHYLACTIC ANTIEMETICS IN BREAST CANCER PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL

Objective: The aim of the study was to prescription pattern prophylactic antiemetics in breast cancer patients. Methods: A retrospective observational carried out. Over a period 3 months, all chemotherapy order sheets patients were collected and evaluated for prophylaxis chemotherapy-induced nausea vomiting (CINV). We compared each antiemetic drug used CINV with international guidelines, National Comprehensive Cancer Network (NCCN). Results: total 103 included study, which 141 physician prescriptions drugs. Approximately 51.06% anticancer agents had high emetic risk, 2.13% moderate 43.26% 3.55% low minimal respectively. Most frequently prescribed paclitaxel 49 (34.75%). About 43.97% regimen found following NCCN guidelines. Conclusion: development institutional policy assessment guidance may improve consistency between prescribing